Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. - Wikidata - wikimedia - TriplyDB

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.

http://www.wikidata.org/entity/Q34764143

about

CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas Immunotherapy for cancer in the central nervous system: Current and future directions Immune Evasion Strategies of Glioblastoma Stress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) Concepts Advances in the treatment of newly diagnosed glioblastoma Overview of current immunotherapeutic strategies for glioma Current vaccine trials in glioblastoma: a review Vaccine therapies in malignant glioma Dendritic Cell Therapy in an Allogeneic-Hematopoietic Cell Transplantation Setting: An Effective Strategy toward Better Disease Control?A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiforme Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention Sui generis: gene therapy and delivery systems for the treatment of glioblastoma Immunotherapy advances for glioblastoma Immunotherapy for primary brain tumors: no longer a matter of privilege Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials Immunotherapy for brain cancer: recent progress and future promise An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma AACR Cancer Progress Report 2014 Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis Heat shock protein vaccines against glioblastoma: from bench to bedside Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.DCVax®-L--developed by Northwest Biotherapeutics Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas.History and current state of immunotherapy in glioma and brain metastasis.A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.Single vs. combination immunotherapeutic strategies for glioma.Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination.Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas Differential glioma-associated tumor antigen expression profiles of human glioma cells grown in hypoxia.Emerging treatment strategies for glioblastoma multiforme Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma

P2860

Q26740520-FBC7FAC8-CD2C-4910-8C0E-EEB702040ECE Q26750765-6233C447-A46A-4756-AA34-6A0C2B152622 Q26765855-EAF3E3D1-2B99-4277-AA2A-3D9791B10375 Q26771706-7D909525-84BE-4A4F-886B-74EFFBE2206B Q26773514-BC65453A-8573-45C3-9110-0C4119242260 Q26776345-17A66E5A-9681-42CE-9459-5667FEAB177F Q26828965-10B2FCC5-BF93-4CF2-AA16-176D98733F9B Q26829328-8B0B6FD9-361C-4B1B-A5E7-2C6FC3ADA788 Q26830857-59227BC7-0C2B-4893-B0E4-81467F16DF8E Q26849375-6EE0148E-4A0A-4575-AEAD-018A497C9C1C Q26850218-3BCED17B-4790-4BA0-957E-089640AF0254 Q26850467-9121BC4E-4F3B-4D54-9470-1978A1580F49 Q26866513-061F3B39-B4C0-4F92-94AA-D6A0ED697621 Q27002510-F7F061B4-C0F5-4ED0-A89A-2D8ACB284B53 Q27012618-44A609BF-DF73-4978-A4E9-91E6BFBCD1BA Q27014829-25DA0659-1E78-4F7F-96CC-EB60BEC08469 Q27015881-1251DB81-D807-4D95-ABF7-3D444F29C513 Q27024830-47730583-FB11-414B-888F-7B29F8B81F21 Q27346723-0CE77F5A-D532-4C5C-83D7-2BB1159B1538 Q27348437-125A23BB-86E8-4BE2-876B-CC73B7687C40 Q28087775-E9B2762B-BEFF-4916-A9AC-A5DE794B4427 Q28730798-440CC6B0-B8E3-4E4A-A2EE-C0F85EBCF18C Q30177343-63ED1625-9DAD-4F69-8D1F-8C5B2A02F6A0 Q30628099-9BFA57F0-E696-44BB-ADDE-3B7D32535853 Q30875456-7F3D575F-A56E-4D8E-9AD5-1BEF477AEEF7 Q31113520-57350741-A50E-447E-A182-328DBF2DE5F8 Q33600115-9FA7C816-68FF-44D8-94F1-C6C7991B3475 Q33656811-28C526E0-F75F-425A-B90C-0F5C48062DD2 Q33668084-C3FD1069-0EBE-4ABD-936E-34400FF45F17 Q33691858-41D4117A-DCC8-4BBD-AE43-9FE325B0EA97 Q33746041-CAFDD45E-8CDA-455F-B8D8-C3C1ACDCEAE8 Q33761585-C2AB143E-9A50-4BA8-83B2-B4A929754AB0 Q33779140-D725A4EE-B285-4A81-BC00-8C92E7287D61 Q33923950-A153F549-EAA7-423E-B431-7F07670D9700 Q34260758-DDBD4AF0-5A61-4562-90E7-F8CD6A6A24AC Q34276759-72CF296C-760D-4549-B093-53F155033A78 Q34399073-865432B6-ACF8-43D3-A3FA-EE379875D5D2 Q34407938-025A4195-398F-4C64-B847-8F630C7C1BCD Q34542656-C46DB370-2EBC-4F62-A539-471B3096E8A2 Q34657329-21298845-9902-4CBA-B737-5214450F436C

P2860

Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy.

http://www.wikidata.org/entity/Q34764143

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Gene expression profile correl ...... dendritic cell immunotherapy.

@ast

Gene expression profile correl ...... dendritic cell immunotherapy.

@en

Gene expression profile correl ...... dendritic cell immunotherapy.

@nl

type

label

Gene expression profile correl ...... dendritic cell immunotherapy.

@ast

Gene expression profile correl ...... dendritic cell immunotherapy.

@en

Gene expression profile correl ...... dendritic cell immunotherapy.

@nl

prefLabel

Gene expression profile correl ...... dendritic cell immunotherapy.

@ast

Gene expression profile correl ...... dendritic cell immunotherapy.

@en

Gene expression profile correl ...... dendritic cell immunotherapy.

@nl

P1433

Q34764143-D820F653-7AE1-4FB4-B672-F61BE54C42AC

P1476

Q34764143-6BF6E239-41DC-453C-A57B-F0B3E6D00FC2

P2093

Q34764143-0768C7D4-BAC3-478E-98DB-5528BA1A390A

Q34764143-27EB6497-715C-4703-8626-7E4D548C5447

Q34764143-3112FD9F-3370-4A48-A3CE-3EF334A3EC45

Q34764143-6E63D89C-9174-4A99-8425-CB667EF48EBC

Q34764143-7709259C-8225-4449-B506-97C79ED16952

Q34764143-99C39DEE-3834-4510-B61A-7190CB2EC845

Q34764143-FC5305F2-BE5B-4CB0-AFA3-6430D273BEAA

P2860

Q34764143-07683093-0956-4B5D-8112-4DA30C56F0AE

Q34764143-08312CF2-E164-4B97-A2B0-C0BE54417A2A

Q34764143-08C94B7E-A649-401A-AAC6-24A229A25B55

Q34764143-10EDB809-94F1-4D6B-90A8-E11F639AB9C1

Q34764143-19BDF10E-7567-4595-9AF9-1389118CB799

Q34764143-1F1C1BA9-D9A3-4157-952C-9FD7C0F08F4A

Q34764143-20842598-DE96-419F-9395-C54BC7A0BBD0

Q34764143-22A8DB56-C356-40B3-9A33-6D5DB1E2C0AA

Q34764143-3077BA1C-7A09-4487-B9E6-99F0848B5A49

Q34764143-3F47DA5B-EFF5-4102-B920-F4F1B39333C4

P304

Q34764143-8770996E-C619-40E7-956F-D31F037B94C9

P31

Q34764143-E6B58EB7-5B62-4F4B-AC4C-86B87818A5C9

P356

Q34764143-34AEA46F-E782-493E-848A-462892E03C96

P407

Q34764143-B10936A9-6641-4963-B947-B81D18092D32

P433

Q34764143-B2D91B7D-1C31-4225-B342-0F67F0FA93AE

P478

Q34764143-CC89DB72-B74C-46A3-8D8F-3D3902ADDE30

P50

Q34764143-5DD7F949-44B1-4C74-993B-B150D5CE6678

P577

Q34764143-2F1D0961-3980-4C81-996A-61A776E5F50E

P698

Q34764143-D830DCD3-D05D-44D4-ABAC-8801CD990A1C

P921

Q34764143-16B327C2-F5AC-4E38-A7E6-AB4235E624EE

Q34764143-3C9F037C-8A4D-4DC2-B6D5-DC68DE574E33

P932

Q34764143-AE4CE6CE-050B-46E6-8D43-EBED7931BE0B

P356

1078-0432.CCR-10-2563

P1433

Clinical Cancer Research

P1476

Gene expression profile correl ...... dendritic cell immunotherapy.

@en

P2093

Ascia Eskin

http://www.w3.org/2001/XMLSchema#string

Horacio Soto

http://www.w3.org/2001/XMLSchema#string

Linda M Liau

http://www.w3.org/2001/XMLSchema#string

Stanley F Nelson

http://www.w3.org/2001/XMLSchema#string

Sylvia K Odesa

http://www.w3.org/2001/XMLSchema#string

Vera Konkankit

http://www.w3.org/2001/XMLSchema#string

William H Yong

http://www.w3.org/2001/XMLSchema#string

P2860

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

The 2007 WHO classification of tumours of the central nervous system

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Celsius: a community resource for Affymetrix microarray data.

Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age

P304

1603-1615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-2563

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Robert M. Prins

P577

2010-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21135147

http://www.w3.org/2001/XMLSchema#string

P921

P932

3071163

http://www.w3.org/2001/XMLSchema#string